Top Markets
#1 Black Phoenix Black Phoenix +167.33%
#2 Islamic Coin Islamic Coin +158.08%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +38.38%
#5 Cryptopia Cryptopia +21.67%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.34%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +17.34%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.13%
#9 DOVU DOVU +12.80%
#10 Test Test +12.79%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Genomic Vision S.A. Genomic Vision S.A.

Genomic Vision S.A.

GV
Clasificación en acciones #41547
Headquartered in Bagneux, France, and established in 2004, Genomic Vision S.A.... Headquartered in Bagneux, France, and established in 2004, Genomic Vision S.A. is a molecular diagnostics and technology company focused on developing sophisticated tools for analyzing individual DNA molecules. These innovations serve both scientific research and in vitro diagnostic purposes. A cornerstone of their offerings is the FiberVision molecular combing platform, which streamlines DNA analysis workflows. This platform integrates FiberComb, a system for stretching single DNA molecules onto vinyl silane glass, with a FiberVision scanner designed to acquire high-resolution images of entire coverslip surfaces automatically. The data is then processed by FiberStudio software, which detects hybridization signals, analyzes results, and generates reports. Supporting these systems, the company provides the FiberPrep DNA extraction kit, producing purified DNA for combing, alongside essential accessories such as custom-treated glass carriers and disposable DNA reservoirs. Genomic Vision also offers specialized FiberProbes, including "Genomic Morse Code" sets for detecting mutations associated with hereditary breast and ovarian cancer (BRCA), as well as for identifying and characterizing structural variations related to hereditary nonpolyposis colorectal cancer, particularly anomalies in the flanking regions of MMR genes. Additionally, their molecular combing services enable clients to validate planned gene editing events, identify substantial unintended modifications (exceeding 1 kilobase), and precisely quantify on-target versus off-target genetic changes. The company reinforces its position through strategic partnerships, including an alliance with Quest Diagnostics and development and research collaborations with La Timone Hospital and the Institut Pasteur, respectively.
Precio por acción
$0.00196068
Última sincronización: 2023-12-01
Capitalización bursátil
$16.64K
Cambio (1 día)
0.01%
Cambio (1 año)
0.00%
País
FR
Comercio Genomic Vision S.A. (GV)

Categoría

Healthcare
Historial de dividendos de Genomic Vision S.A. (GV)
Genomic Vision S.A. (símbolo bursátil: GV) realizó un total de 0 pagos de dividendos.
La suma de todos los dividendos (ajustados por splits de acciones) es: 0.00
Rentabilidad por dividendo (TTM): 0
Pagos de dividendos de Genomic Vision S.A. (GV) desde 2026 hasta 2026
Pagos anuales de dividendos
Año Dividendo (ajustado por splits de acciones) Cambiar
Not enough data for the provided dates.
Lista de todos los pagos de dividendos
Año Dividendo Cambiar
Not enough data for the provided dates.
Pagos de dividendos de empresas similares o competidoras
Empresa Número de pagos de dividendos País
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
60.00%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
134.00%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
0.00%
CN
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
0.00%
US
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
0.00%
US